Literature DB >> 3169010

Persistence of micronuclei in peripheral blood normochromatic erythrocytes of subchronically benzene-treated male mice.

K Rithidech1, W W Au, V M Ramanujam, E B Whorton, M S Legator.   

Abstract

The kinetics of micronucleus (MN) induction and decline in blood normochromatic erythrocytes (NCE) of mice subchronically exposed to benzene was investigated during and after exposure. Swiss (ICR) male mice (10/group) were given 0.0, 36.6, 73.2, and 146.4 mg/kg body weight benzene by gavage daily for 14 days, except for days 5 and 10. The frequency of MN increased significantly (P less than .001) during benzene treatment as a function of both concentration and time. Eleven days after exposure the levels of MN were higher than those observed at the end of exposure. After an initial rapid decline in the frequency of MN from 11 to 18 days postexposure, the decline became linear with time through 60 days postexposure. Using linear regression analysis, the MN level in each treatment group was predicted to reach control levels by approximately 85 days post-treatment. Dose-dependent suppression and recovery of erythropoiesis, estimated by polychromatic erythrocyte frequency, were observed in the 1st and 2nd weeks of exposure, respectively. Red blood cell (RBC) production was markedly increased in the first 3 weeks after benzene treatment. At later times the rate of production of the RBC returned to normal and may account for the linear decline observed in MN frequency. This research indicates that the frequency of MN is dose and duration dependent, while the decline in MN frequency after the end of benzene exposure can be related to changes in the kinetics of erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169010     DOI: 10.1002/em.2860120306

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  2 in total

1.  Identification of proteins secreted into the medium by human lymphocytes irradiated in vitro with or without adaptive environments.

Authors:  Kanokporn Noy Rithidech; Xianyin Lai; Louise Honikel; Paiboon Reungpatthanaphong; Frank A Witzmann
Journal:  Health Phys       Date:  2012-01       Impact factor: 1.316

2.  Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant--Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation.

Authors:  Bélin Poletto Mezzomo; Ana Luisa Miranda-Vilela; Cesar Koppe Grisolia
Journal:  Toxins (Basel)       Date:  2015-12-09       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.